Answers are grounded in this paper and cite their sources.
Marine biota functions as a reservoir harboring highly diverse bioactive proteins and polypeptides for drug development. Although stony corals are renowned for their high productivity and the crucial role of maintaining ecological balance in the marine ecosystem, investigations concerning structural and functional diversity of their proteins and polypeptides are lagging. Herein, we present a comprehensive report on the repertoire of venom-related proteins and peptides from the coral Porites lutea through transcriptome analysis. Furthermore, a novel ∼6 kDa Kunitz-like polypeptide (PlKuz1) was discovered through a homology search, which was then characterized for its sequence and three-dimensional structure. Electrophysiological experiments and molecular docking analysis revealed that PlKuz1 can specifically inhibit the K v 1.3 channel with an IC 50 of approximately 3 μM. In addition, chromogenic assay revealed that PlKuz1 exhibited a robust plasma kallikrein inhibition effect within the concentration range of 1.25–10 μM. In vitro experiments demonstrated that, at 0.3–3 μM, PlKuz1 exerted neuroprotective and anti-inflammatory effects in 6-OHDA-induced PC12 cells and LPS-stimulated BV2 cells, respectively. Moreover, in vivo experimental results indicated that at the same dosage, PlKuz1 mitigated locomotor deficits and protected against dopamine neuronal loss in a 6-OHDA-induced Parkinson's disease model in zebrafish larvae. Additionally, PlKuz1 alleviated LPS-induced production of proinflammatory cytokines and neutrophil migration in zebrafish larvae. Our results highlighted its anti-Parkinson's disease and anti-inflammatory effects in different in vitro cell models and in vivo zebrafish models, and that these effects may involve its K v 1.3 channel and plasma kallikrein inhibitory activities. Our study expands understanding of venom-related proteins and peptides in stony corals and provides new insights into the discovery and development of potential neuroprotective and anti-inflammatory drugs derived from these neglected marine species. • We clarified the venom-related proteins and polypeptides in P. lutea for the first time. • The novel peptide PlKuz1 potently inhibits Kv1.3 channels and plasma kallikrein, and the targets of PlKuz1 have been clearly verified. • PlKuz1 shows neuroprotective effects in 6-OHDA-induced Parkinson’s models and anti-inflammatory activity, highlighting its therapeutic potential for Parkinson’s disease and neuroinflammation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: